Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 18

1.

Commentary on the State-of-the-Science Conference on the role of active surveillance in the management of men with localized prostate cancer.

Hall IJ, Richardson LC.

J Natl Cancer Inst Monogr. 2012 Dec;2012(45):135-9. doi: 10.1093/jncimonographs/lgs040. No abstract available.

PMID:
23271762
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

National Institutes of Health State-of-the-Science Conference: role of active surveillance in the management of men with localized prostate cancer.

Ganz PA, Barry JM, Burke W, Col NF, Corso PS, Dodson E, Hammond ME, Kogan BA, Lynch CF, Newcomer L, Seifter EJ, Tooze JA, Viswanath K, Wessells H.

Ann Intern Med. 2012 Apr 17;156(8):591-5. doi: 10.7326/0003-4819-156-8-201204170-00401. Epub 2012 Feb 20. No abstract available.

PMID:
22351514
[PubMed - indexed for MEDLINE]
3.

An evidence review of active surveillance in men with localized prostate cancer.

Ip S, Dahabreh IJ, Chung M, Yu WW, Balk EM, Iovin RC, Mathew P, Luongo T, Dvorak T, Lau J.

Evid Rep Technol Assess (Full Rep). 2011 Dec;(204):1-341. Review.

PMID:
23126653
[PubMed - indexed for MEDLINE]
Free Article
4.

NIH State-of-the-Science Conference Statement: Role of active surveillance in the management of men with localized prostate cancer.

Ganz PA, Barry JM, Burke W, Col NF, Corso PS, Dodson E, Hammond ME, Kogan BA, Lynch CF, Newcomer L, Seifter EJ, Tooze JA, Viswanath KV, Wessells H.

NIH Consens State Sci Statements. 2011 Dec 5-7;28(1):1-27.

PMID:
23392076
[PubMed - indexed for MEDLINE]
5.

Active surveillance for prostate cancer: past, present and future.

Singer EA, Kaushal A, Turkbey B, Couvillon A, Pinto PA, Parnes HL.

Curr Opin Oncol. 2012 May;24(3):243-50. doi: 10.1097/CCO.0b013e3283527f99. Review.

PMID:
22450149
[PubMed - indexed for MEDLINE]
6.
7.

Active surveillance in prostate cancer: the need to standardize.

Filella X, Alcover J, Molina R.

Tumour Biol. 2011 Oct;32(5):839-43. doi: 10.1007/s13277-011-0193-2. Epub 2011 May 28. Review.

PMID:
21625940
[PubMed - indexed for MEDLINE]
8.

Screening for prostate cancer: a review of the evidence for the U.S. Preventive Services Task Force.

Chou R, Croswell JM, Dana T, Bougatsos C, Blazina I, Fu R, Gleitsmann K, Koenig HC, Lam C, Maltz A, Rugge JB, Lin K.

Ann Intern Med. 2011 Dec 6;155(11):762-71. doi: 10.7326/0003-4819-155-11-201112060-00375. Epub 2011 Oct 7. Review.

PMID:
21984740
[PubMed - indexed for MEDLINE]
9.

Clarifying uncertainty regarding detection and treatment of early-stage prostate cancer.

Wilt TJ.

Semin Urol Oncol. 2002 Feb;20(1):10-7. Review.

PMID:
11828353
[PubMed - indexed for MEDLINE]
10.

Watchful waiting for prostate cancer: a review article.

Chodak GW, Warren KS.

Prostate Cancer Prostatic Dis. 2006;9(1):25-9. Review.

PMID:
16402090
[PubMed - indexed for MEDLINE]
11.

Critical review: is watchful waiting a viable management option for older men with prostate cancer?

Bailey DE Jr, Wallace M.

Am J Mens Health. 2007 Mar;1(1):18-28. doi: 10.1177/1557988306294161. Review.

PMID:
19482780
[PubMed - indexed for MEDLINE]
12.

Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control.

Weir HK, Thun MJ, Hankey BF, Ries LA, Howe HL, Wingo PA, Jemal A, Ward E, Anderson RN, Edwards BK.

J Natl Cancer Inst. 2003 Sep 3;95(17):1276-99. Review. Erratum in: J Natl Cancer Inst. 2003 Nov 5;95(21):1641.

PMID:
12953083
[PubMed - indexed for MEDLINE]
Free Article
13.

Active surveillance for favorable-risk prostate cancer: background, patient selection, triggers for intervention, and outcomes.

Klotz L.

Curr Urol Rep. 2012 Apr;13(2):153-9. doi: 10.1007/s11934-012-0242-4. Review.

PMID:
22477615
[PubMed - indexed for MEDLINE]
14.

The watchful waiting management option for older men with prostate cancer: state of the science.

Wallace M, Bailey D Jr, O'Rourke M, Galbraith M.

Oncol Nurs Forum. 2004 Nov 16;31(6):1057-66. Review.

PMID:
15547629
[PubMed - indexed for MEDLINE]
15.

Active surveillance versus radical treatment for favorable-risk localized prostate cancer.

Klotz L.

Curr Treat Options Oncol. 2006 Sep;7(5):355-62. Review.

PMID:
16904052
[PubMed - indexed for MEDLINE]
16.

Active surveillance for prostate cancer: overview and update.

Klotz L.

Curr Treat Options Oncol. 2013 Mar;14(1):97-108. doi: 10.1007/s11864-012-0221-5. Review.

PMID:
23318986
[PubMed - indexed for MEDLINE]
17.

Active surveillance for low-risk prostate cancer: selection of patients and predictors of progression.

Dall'Era MA, Konety BR.

Nat Clin Pract Urol. 2008 May;5(5):277-83. doi: 10.1038/ncpuro1058. Epub 2008 Feb 19. Review.

PMID:
18285752
[PubMed - indexed for MEDLINE]
18.

Active surveillance for low-risk prostate cancer: an update.

Lawrentschuk N, Klotz L.

Nat Rev Urol. 2011 Apr 26;8(6):312-20. doi: 10.1038/nrurol.2011.50. Review.

PMID:
21519351
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk